Premium
INTRALESIONAL HUMAN FIBROBLAST INTERFERON IN COMMON WARTS
Author(s) -
Niimura Michihito
Publication year - 1983
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.1983.tb01130.x
Subject(s) - placebo , fibroblast , interferon , common warts , medicine , adverse effect , dermatology , surgery , pathology , immunology , biology , human papillomavirus , cell culture , alternative medicine , genetics
In a double‐blind trial, patients with bilateral common warts of the extremities were treated at weekly intervals with intralesional injections of either human fibroblast interferon or placebo. More than 81% of the interferon‐treated extremities were either cured or responded effectively to therapy. Only 17% of the placebo‐treated lesions responded in this fashion. A statistical analysis of these data confirms the effectiveness of intralesional interferon therapy. No adverse effects were observed.